BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 32927853)

  • 1. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation.
    Recchiuti A; Isopi E; Romano M; Mattoscio D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.
    Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M
    Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential.
    Li QF; Hao H; Tu WS; Guo N; Zhou XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7442-7453. PubMed ID: 32706084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of inflammation in oral diseases.
    Eltay EG; Van Dyke T
    Pharmacol Ther; 2023 Jul; 247():108453. PubMed ID: 37244405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.
    Tang S; Wan M; Huang W; Stanton RC; Xu Y
    Mediators Inflamm; 2018; 2018():2380319. PubMed ID: 29674943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biosynthetic pathways of the protectins.
    Stenvik Haatveit Å; Hansen TV
    Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106787. PubMed ID: 37806439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.
    Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis.
    Recchiuti A; Mattoscio D; Isopi E
    Front Pharmacol; 2019; 10():252. PubMed ID: 31001110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation.
    Duvall MG; Levy BD
    Eur J Pharmacol; 2016 Aug; 785():144-155. PubMed ID: 26546247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination.
    Norling LV; Serhan CN
    J Intern Med; 2010 Jul; 268(1):15-24. PubMed ID: 20497301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialized pro-resolving mediator network: an update on production and actions.
    Chiang N; Serhan CN
    Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation.
    Ferreira I; Falcato F; Bandarra N; Rauter AP
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators.
    Perez-Hernandez J; Chiurchiù V; Perruche S; You S
    Front Immunol; 2021; 12():768133. PubMed ID: 34868025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
    Serhan CN; Chiang N
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S200-15. PubMed ID: 17965751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid.
    Beyer MP; Videla LA; Farías C; Valenzuela R
    Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.
    Díaz Del Campo LS; Rodrigues-Díez R; Salaices M; Briones AM; García-Redondo AB
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural resolution of inflammation.
    Freire MO; Van Dyke TE
    Periodontol 2000; 2013 Oct; 63(1):149-64. PubMed ID: 23931059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.
    Kotlyarov S; Kotlyarova A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.